ARCHIVES

Novartis Begins Study Of Femara And Zometa In Postmenopausal Early Breast Cancer

This article is from The Cancer Letter archive.

Vol. 25 No. 12 | December 27, 2002

Download PDF Visit The Full Archive

Related Articles

FDA, NIH Streamline Approvals For Gene Therapy Studies

June 16, 1995

Albino African Skin Cancer Study To Be Reevaluated

April 11, 1980

Age-adjusted cancer incidence and mortality down slightly, annual report finds.

June 4, 2004

Phase III Trial Retrospective Analysis Finds Talimogene Laherparepvec Reduced Tumors

March 28, 2014

ASSIST evaluation finds proven methods help states fight tobacco.

December 5, 2003

FDA Proposal To Regulate Tobacco Wins Support Of NCI, Oncology Societies

September 8, 1995